Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996047 · ClinicalTrials.gov registry record
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
A clinical trial, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 3,341
- Enrollment target
NCT00996047: Completed study, sponsored by SWOG Cancer Research Network.
NCT00996047 is a clinical trial that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 3,341 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00996047 has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 3,341 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at bone marrow and blood samples from patients with leukemia or other hematopoietic cancers.
Interventions
- GENETIC cytogenetic analysis
- GENETIC fluorescence in situ hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,341 participants |
| Start Date | 1991-07 |
| Est. Completion | 2012-01 |
What the finished NCT00996047 record still lists
NCT00996047 is an observational study that tracks outcomes without assigning an intervention. Its 3,341 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which cytogenetic analysis is the first listed.
NCT00996047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00996047 about?
NCT00996047 is a clinical study titled "S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers". RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research stu...
What is the current status of trial NCT00996047?
This trial is currently completed. The enrollment target is 3,341 participants. The study started on 1991-07. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00996047?
The interventions under investigation include: cytogenetic analysis (GENETIC), fluorescence in situ hybridization (GENETIC).
Who is sponsoring clinical trial NCT00996047?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06880055 · 3,375 participants
Shield Post-Approval Study Protocol
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
- NCT07214610 · 3,300 participants · NA
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia